Conal Hayton

Conal Hayton is an Honorary Senior Lecturer in Respiratory Medicine at the University of Manchester. He holds external clinical roles as a Consultant Respiratory Physician at Manchester University NHS Foundation Trust and previously served as a Clinical Research Fellow in ILD at the University Hospital of South Manchester NHS Foundation Trust. His research focuses on breathomics, volatile organic compounds, and idiopathic pulmonary fibrosis, contributing to UN Sustainable Development Goals related to health and disease understanding.

• Education:
• Doctor of Philosophy (2022): Volatile organic compounds in idiopathic pulmonary fibrosis, Faculty of Biology, Medicine and Health
• Bachelor of Medicine and Surgery (2009), The University of Manchester
• Bachelor of Science (2008), Pharmacology and Physiology, The University of Manchester

Research Interests: Hayton’s work centers on respiratory diseases, particularly interstitial lung diseases (ILD) and idiopathic pulmonary fibrosis (IPF). He investigates breath biomarkers for disease diagnosis and progression, including volatile organic compounds (VOCs) and their metabolic pathways. His studies also address clinical management strategies for ILD patients, such as antifibrotic therapies and diagnostic pathway optimizations.

Articles Overview: His publications span biomarker discovery, clinical outcomes in ILD, and therapeutic efficacy. Recent work includes studies on VOC-lung function correlations and TGF-β-induced metabolic changes in lung cells. The articles emphasize translational research bridging basic science and clinical practice.

• Scientific Awards:
  • Action for Pulmonary Fibrosis American Thoracic Society Travel Fellowship (2018)
  • American Thoracic Society International Trainee Scholarship Award (2018)

Grants & Advising: Hayton has supervised doctoral research on VOCs in IPF and collaborates with institutions on ILD clinical pathways. His grants likely focus on biomarker validation and antifibrotic drug trials, though specific details aren’t listed.

Labs & Teams: Active in the Division of Immunology, Immunity to Infection and Respiratory Medicine, collaborating with groups like the British Thoracic Society and European Respiratory Society. His work involves multidisciplinary teams analyzing clinical and molecular data to advance ILD management.